AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,968 | +4758.3% | 19,638 | +4935.4% | 0.00% | – |
Q2 2023 | $1,152 | +115100.0% | 390 | -29.5% | 0.00% | – |
Q1 2023 | $1 | -100.0% | 553 | -83.4% | 0.00% | – |
Q3 2022 | $11,000 | +22.2% | 3,334 | +38.2% | 0.00% | – |
Q2 2022 | $9,000 | -70.0% | 2,412 | -68.5% | 0.00% | – |
Q1 2022 | $30,000 | +7.1% | 7,657 | +39.4% | 0.00% | – |
Q4 2021 | $28,000 | -62.7% | 5,491 | -50.9% | 0.00% | -100.0% |
Q3 2021 | $75,000 | +316.7% | 11,191 | +404.3% | 0.00% | – |
Q2 2021 | $18,000 | -52.6% | 2,219 | -55.5% | 0.00% | -100.0% |
Q1 2021 | $38,000 | +11.8% | 4,988 | -24.7% | 0.00% | 0.0% |
Q4 2020 | $34,000 | +3.0% | 6,625 | -2.4% | 0.00% | – |
Q3 2020 | $33,000 | -26.7% | 6,788 | +0.2% | 0.00% | -100.0% |
Q2 2020 | $45,000 | – | 6,774 | +56350.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 12 | -99.9% | 0.00% | -100.0% |
Q4 2019 | $75,000 | +21.0% | 8,740 | -29.8% | 0.01% | +50.0% |
Q3 2019 | $62,000 | +51.2% | 12,454 | +52.5% | 0.00% | +100.0% |
Q1 2019 | $41,000 | +28.1% | 8,164 | +103.2% | 0.00% | 0.0% |
Q3 2018 | $32,000 | +357.1% | 4,018 | +631.9% | 0.00% | +100.0% |
Q4 2017 | $7,000 | -74.1% | 549 | -82.0% | 0.00% | -66.7% |
Q2 2017 | $27,000 | – | 3,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
Renaissance Technologies | 425,179 | $1,212 | 0.00% |
Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |